The prc PARTNERS interviewprc PARTNERS is a shareholder as everyone else? Or maybe not!
I think they were given information pre-deal based on:
- the interview is very polished - I like it, but very hard to accomplish in one day
- getting hold of three key management resources during the ongoing conference?
- the reference to share price close Friday June 10th on investment highlights
That raises the question of they bought shares based on in-the-know pre-deal?!
It also suggest that the close relationship indicates that the numbers published by prc PARTNERS pre- and post-deal are related to the real world. Could of course be debated.Was it $20M upfront?
Nevertheless, there are interesting breadcrumbs:
- AbbVie seems to already have started the product development which is very positive of course
- animal health deal expected to be closed this autumn
- upfront is invested in accelerated development
- $40M royalty equals about 1.86 CAD per share at P/E 10 and 275M shares - does prc PARTNERS speculate or are they in-the-know? Doesn't really matter as the numbers seems realistic anyway.
Sirona Biochem states on Twitter that "There are many more news to come in the next days" - does it refer to the post-deal interview or something else? I would be very surprised if there's more to bring to the market this week given the prc PARTNERS interview that covers a lot.